Kunststoff KG Nehl v Häfele (CFI, 18 April 2025)
| Date | 18 April 2025 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Central Division - Section |
| Type of action | Generic Order |
| Registry reference | ORD_18972/2025 |
| Parties | Kunststoff KG Nehl & Co. v. Häfele SE & Co. KG |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 18 April 2025 (UPC_CFI_526/2024, ORD_18972/2025), Judge-rapporteur Kupecz of the Munich Central Division prepared the oral hearing in the revocation action brought by Kunststoff KG Nehl & Co. against Häfele SE & Co. KG concerning EP 3 767 151. He set the value in dispute at EUR 500,000 (ceiling for recoverable costs: EUR 56,000), limited the examination of the 80 auxiliary requests, and disregarded a new attack and part of the rejoinder. The order gives a useful benchmark for the number of auxiliary requests a panel will entertain.
Question
May the patentee file 80 conditional auxiliary requests, and may the claimant raise a new inventive step attack in its reply?
Decision
Eighty requests are not a reasonable number: parallel proceedings do not justify it, the technology is of limited complexity and the lack of a clear hierarchy makes preparation unduly difficult. Rejecting the application to amend as a whole would, however, go too far: the panel will deal with the requests in the order filed until a reasonable number is reached, in all likelihood up to 10, Häfele may limit or re-order them until 7 May 2025. In the judge’s provisional view, the attack based on D16, which could and should have been raised in the statement for revocation, will be disregarded, whether Rule 263 or Rule 9.2 applies. Parts I to III of the rejoinder, which reopen the debate on the patent as granted, will not be taken into account.
Key points for practice
- A new attack raised in reply must come with an explanation of why it could not have been raised earlier.
- Practical point: a patentee should itself rank a limited number of auxiliary requests, otherwise only the first ones filed will be considered.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 65(2) and (3)
- Rules of Procedure
- Rules 9.2, 30.1, 30.2, 32.3, 55 and 263
- European Patent Convention
- Art. 100 and Art. 138(1)
- Case law cited
- NJOY v Juul Labs, Paris Central Division, 5 November 2024, Tandem Diabetes Care v Roche Diabetes Care, Paris Central Division, 18 December 2024, DexCom v Abbott, Paris Local Division, 11 December 2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantKunststoff KG Nehl & Co.3 decisions in the corpusFollow this party
- defendantHäfele SE & Co. KG3 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic Order
- Outcome (Dhenne Avocats summary)
- Les 80 requêtes subsidiaires ne seront examinées que dans l'ordre de dépôt jusqu'à un nombre raisonnable, vraisemblablement 10. L'attaque nouvelle fondée sur D16 et une partie de la duplique sont écartées.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 767 151mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Tandem Diabetes Care Europe v Roche Diabetes Care (CFI, 18 December 2024) cited in this record
- DexCom v Abbott Diagnostics (CFI, 11 December 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 767 151 | Mentioned in the analysis (role not qualified) Also mentioned in 2 other decision(s): Häfele SE & Co v Kunststoff KG Nehl & Co (CFI, 25 November 2024) · Kunststoff KG Nehl v Häfele (CFI, 22 May 2025) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.